Mineralys Therapeutics, Inc. (MLYS)

Insiders sold $42.1M in the past 12 months, 60% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Oct 2 for a sale on Sep 30. Jon Congleton sold 75K shares ($1.9M) under a disclosed plan. Filing